Tech Company Financing Transactions
Oviva Therapeutics Funding Round
Oviva Therapeutics closed a $11.5 million Seed investment round on 5/19/2022. Investors included Cambrian Biopharma.
Transaction Overview
Company Name
Announced On
5/19/2022
Transaction Type
Venture Equity
Amount
$11,500,000
Round
Seed
Investors
Proceeds Purpose
This collaboration with MGH will be one of the first of its kind to develop, test and bring to market new therapeutics specifically designed to improve women's healthspan through improving ovarian health.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
New York, NY 10001
USA
New York, NY 10001
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Oviva's mission is to address the vast unmet need in women's health by driving research and clinical development targeting ovarian physiology, and by expanding funding and awareness in this space. Age-related decline in ovarian function leads to adverse health outcomes in women across the board.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daisy Robinton
Co-Founder
Patricia Donahoe
Co-Founder
David Pépin
Browse more venture capital transactions:
Prev: 5/19/2022: Belong Home venture capital transaction
Next: 5/19/2022: Everstream Analytics venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs